Bronchiectasis and deteriorating lung function in agammaglobulinaemia despite immunoglobulin replacement therapy.

MLA

Stubbs, A., et al. “Bronchiectasis and Deteriorating Lung Function in Agammaglobulinaemia despite Immunoglobulin Replacement Therapy.” Clinical and Experimental Immunology, vol. 191, no. 2, Feb. 2018, pp. 212–19. EBSCOhost, https://doi.org/10.1111/cei.13068.

APA

Stubbs, A., Bangs, C., Shillitoe, B., Edgar, J. D., Burns, S. O., Thomas, M., Alachkar, H., Buckland, M., McDermott, E., Arumugakani, G., Jolles, S., Herriot, R., & Arkwright, P. D. (2018). Bronchiectasis and deteriorating lung function in agammaglobulinaemia despite immunoglobulin replacement therapy. Clinical and Experimental Immunology, 191(2), 212–219. https://doi.org/10.1111/cei.13068

Chicago

Stubbs, A, C Bangs, B Shillitoe, J D Edgar, S O Burns, M Thomas, H Alachkar, et al. 2018. “Bronchiectasis and Deteriorating Lung Function in Agammaglobulinaemia despite Immunoglobulin Replacement Therapy.” Clinical and Experimental Immunology 191 (2): 212–19. doi:10.1111/cei.13068.